Predictors of long-term outcome after stent implantation in a saphenous vein graft

American Journal of Cardiology

Volumn 83, Issue 5, 1999, Pages 681-686

  Le May, Michel R ^a   Labinaz, Marino ^a   Marquis, Jean François ^a   Laramée, Louise A ^a   O'Brien, Edward R ^a   Williams, William L ^a   Jelley, Jennifer L ^a   Woodend, Kirsten ^a   Higginson, Lyall A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CORONARY STENT; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT OCCLUSION; GRAFT PATENCY; GRAFT PRESERVATION; HEART INFARCTION; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTILIPEMIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GRAFT OCCLUSION, VASCULAR; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REOPERATION; RETREATMENT; SAPHENOUS VEIN; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033104190     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00970-9     Document Type: Article

References (15)

1. Piana R.N., Moscucci M., Cohen D.J., Kugelmass A.D., Senerchia C., Kuntz R.E., Baim D.S., Carrozza J.P. Jr. Palmaz-Schatz stenting for treatment of focal vein graft stenosis immediate results and long-term outcome . J Am Coll Cardiol. 23:1994;1296-1304.
2. de Jaegere P.P., van Domburg R.T., Feyter P.J., Ruygrok P.N., van der Giessen W.J., van den Brand M.J., Serruys P.W. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol. 28:1996;89-96.
3. Waksman R., Weintraub W.S., Ghazzal Z., Scott N.A., Shen Y., King S.B. III, Douglas J.S. Jr. Short- and long-term outcome of narrowed saphenous vein bypass graft a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty . Am Heart J. 134:1997;274-281.
4. Frimerman A., Rechavia E., Eigler N., Payton M.R., Makkar R., Litvack F. Long-term follow-up of a high-risk cohort after stent implantation in saphenous vein grafts. J Am Coll Cardiol. 30:1997;1277-1283.
5. Colombo A., Hall P., Almagor Y., Maiello L., Gaglione A., Nakamura S., Borrione M., Goldberg S.L., Finci L., Tobis J. Results of intravascular ultrasound guided coronary stenting without subsequent anticoagulation. J Am Coll Cardiol. 23:1994;335A.
6. Mehan V.K., Salzmann C., Kaufmann U., Meier B. Coronary stenting without anticoagulation. Cathet Cardiovasc Diagn. 34:1995;137-140.
7. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., Ludbrook P., et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase 1 a comparison between intravenous tissue plasminogen activator and intravenous streptokinase . Circulation. 76:1987;142-154.
8. FitzGibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., Burton J.R. Coronary bypass graft fate and patient outcome angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years . J Am Coll Cardiol. 28:1996;616-626.
9. Cairns J.A., Gill J., Morton B., Roberts R., Gent M., Hirsh J., Holder D., Finnie K., Marquis J.F., Naqvi S., Cohen E. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation. 94:1996;1553-1560.
10. Wong S.C., Baim D.S., Schatz R.A., Teirstein P.S., King S.B. 3rd, Curry R.C. Jr, Heuser R.R., Ellis S.G., Cleman M.W., Overlie P., Hirshfeld J.W., Walker C.M., Litvack F., Fish D., Brinker J., Buchbinder M., Goldberg S., Chuang Y.C., Leon M.B. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. Am Coll Cardiol. 26:1995;704-712.
11. Savage M.P., Douglas J.S. Jr, Fischman D.L., Pepine C.J., King S.B. III, Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med. 337:1997;740-747.
12. Ellis S.G., Brener S.J., DeLuca S., Tuzcu E.M., Raymond R.E., Whitlow P.L., Topol E.J. Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions. Am J Cardiol. 79:1997;1460-1464.
13. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med. 336:1997;153-162.
14. Schomig A., Neumann F.J., Kastrati A., Schuhlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E.M., Richardt G., Alt E., Schmitt C., Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
15. Kastrati A., Schuhlen H., Hausleiter J., Walter H., Zitzmann-Roth E., Hadamitzky M., Elezi S., Ulm K., Dirschinger J., Neumann F.J., Schomig A. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial . Circulation. 96:1997;462-467.